The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1–deficient mice
Open accessAbstract
Liver IGF-1-deficient (LID) mice have a 75% reduction in circulating IGF-1 levels and, as a result, a fourfold increase in growth hormone (GH) secretion. To block GH action, LID mice were crossed with GH antagonist (GHa) transgenic mice. Inactivation of GH action in the resulting LID + GHa mice led to decreased blood glucose and insulin levels and improved peripheral insulin sensitivity. Hyperinsulinemic-euglycemic clamp studies showed that LID mice exhibit severe insulin resistance. In contrast, expression of the GH antagonist transgene in LID + GHa mice led to enhanced insulin sensitivity and increased insulin-stimulated glucose uptake in muscle and white adipose tissue. Interestingly, LID + GHa mice exhibit a twofold increase in white adipose tissue mass, as well as increased levels of serum-free fatty acids and triglycerides, but no increase in the triglyceride content of liver and muscle. In conclusion, these results show that despite low levels of circulating IGF-1, insulin sensitivity in LID mice could be improved by inactivating GH action, suggesting that chronic elevation of GH levels plays a major role in insulin resistance. These results suggest that IGF-1 plays a role in maintaining a fine balance between GH and insulin to promote normal carbohydrate and lipid metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659
Normal growth and development in the absence of hepatic insulin-like growth factor I
Yakar, S., Liu, J.-L., Stannard, B., Butler, A., Accili, D., Sauer, B., & LeRoith, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7324 · Cited by 1,420
Self-citationSalomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326
Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., et al. (2001) · Nature Medicine · doi:10.1038/83348 · Cited by 1,170
Reddy, J. K., & Hashimoto, T. (2001) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.21.1.193 · Cited by 959
SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200444200 · Cited by 904
Aoyama, T., Peters, J. M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T., & Gonzalez, F. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5678 · Cited by 863
SHIMOMURA, I. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00009-5 · Cited by 855
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822 · cited 1×
“The excessive fat tissue is distributed in visceral and truncal areas (58, 59).”
BackgroundAmerican Physiological Society
Greene, C. W. (1922) · Science · doi:10.1126/science.55.1435.708 · Cited by 790
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
van der Lely, A. J., Hutson, R. K., Trainer, P. J., Besser, G. M., Barkan, A. L., Katznelson, L., Klibanski, A., Herman-Bonert, V., Melmed, S., Vance, M. L., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06844-1 · Cited by 645
Effect of Growth Hormone on Carbohydrate and Lipid Metabolism
DAVIDSON, M. B. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-2-115 · Cited by 573
SOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling
Emanuelli, B., Peraldi, P., Filloux, C., Sawka-Verhelle, D., Hilton, D., & Van Obberghen, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.15985 · Cited by 468
Liver-Specific igf-1 Gene Deletion Leads to Muscle Insulin Insensitivity
Yakar, S., Liu, J.-L., Fernandez, A. M., Wu, Y., Schally, A. V., Frystyk, J., Chernausek, S. D., Mejia, W., & Le Roith, D. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1110 · Cited by 343
Self-citationTroglitazone action is independent of adipose tissue.
Burant, C. F., Sreenan, S., Hirano, K., Tai, T. A., Lohmiller, J., Lukens, J., Davidson, N. O., Ross, S., & Graves, R. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119839 · Cited by 334
Kim, J. K., Michael, M. D., Previs, S. F., Peroni, O. D., Mauvais-Jarvis, F., Neschen, S., Kahn, B. B., Kahn, C. R., & Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8305 · Cited by 331 · cited 2×
“98 The Journal of Clinical Investigation | January 2004 | Volume 113 | Number 1 oped by Jason Kim and Gerald Shulman (26).”
BackgroundLeptin Receptors Expressed on Pancreatic β-Cells
Kieffer, T. J., Heller, R. S., & Habener, J. F. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1059 · Cited by 326
Adams, T. E., Hansen, J. A., Starr, R., Nicola, N. A., Hilton, D. J., & Billestrup, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1285 · Cited by 309
Suppressors of Cytokine Signaling-1 and -6 Associate with and Inhibit the Insulin Receptor
Mooney, R. A., Senn, J., Cameron, S., Inamdar, N., Boivin, L. M., Shang, Y., & Furlanetto, R. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010579200 · Cited by 282
Argetsinger, L. S., Hsu, G. W., Myers, M. G., Billestrup, N., White, M. F., & Carter-Su, C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14685 · Cited by 246
Insulin Hypersensitivity and Physiological Insulin Antagonists
De Bodo, R. C., & Altszuler, N. (1958) · Physiological Reviews · doi:10.1152/physrev.1958.38.3.389 · Cited by 225
Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action
Hansen, I., Tsalikian, E., Beaufrere, B., Gerich, J., Haymond, M., & Rizza, R. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.250.3.e269 · Cited by 215
Torpor in mice is induced by both leptin-dependent and -independent mechanisms
Gavrilova, O., Leon, L. R., Marcus-Samuels, B., Mason, M. M., Castle, A. L., Refetoff, S., Vinson, C., & Reitman, M. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14623 · Cited by 210
Role of the peroxisome proliferator‐activated receptor in cytochrome P450 4A gene regulation
Johnson, E. F., Palmer, C. N. A., Griffin, K. J., & Hsu, M. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.11.8836037 · Cited by 180
SÖNKSEN, P. H., GREENWOOD, F. C., ELLIS, J. P., LOWY, C., RUTHERFORD, A., & NABARRO, J. D. N. (1967) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-27-10-1418 · Cited by 176
Chen, W. Y., White, M. E., Wagner, T. E., & Kopchick, J. J. (1991) · Endocrinology · doi:10.1210/endo-129-3-1402 · Cited by 171
Self-citationKrebs, D. L., Uren, R. T., Metcalf, D., Rakar, S., Zhang, J., Starr, R., Souza, D. P. D., Hanzinikolas, K., Eyles, J. L., Connolly, L., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4567-4578.2002 · Cited by 163
Growth Hormone-promoted Tyrosyl Phosphorylation of SHC Proteins and SHC Association with Grb2
VanderKuur, J., Allevato, G., Billestrup, N., Norstedt, G., & Carter-Su, C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7587 · Cited by 160
Kawazoe, Y., Naka, T., Fujimoto, M., Kohzaki, H., Morita, Y., Narazaki, M., Okumura, K., Saitoh, H., Nakagawa, R., Uchiyama, Y., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.263 · Cited by 160
Richelsen, B., Pedersen, S. B., Børglum, J. D., Møller–Pedersen, T., Jørgensen, J. O. L., & Jørgensen, J. O. L. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.2.e211 · Cited by 142
VanderKuur, J. A., Butch, E. R., Waters, S. B., Pessin, J. E., Guan, K., & Carter‐Su, C. (1997) · Endocrinology · doi:10.1210/endo.138.10.5453 · Cited by 131
GROWTH HORMONE AND THE METABOLISM OF CARBOHYDRATE AND LIPID IN ADIPOSE TISSUE*
GOODMAN, H. M. (1968) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1968.tb20367.x · Cited by 124
Tanizawa, Y., Okuya, S., Ishihara, H., Asano, T., Yada, T., & Oka, Y. (1997) · Endocrinology · doi:10.1210/endo.138.10.5576 · Cited by 118
Argetsinger, L. S., Norstedt, G., Billestrup, N., White, M. F., & Carter‐Su, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29415 · Cited by 118
Dominici, F. P., Diaz, G. A., Bartke, A., Kopchick, J., & Turyn, D. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1660579 · Cited by 117
Self-citationBougneres, P. F., Artavia, E., Ferré, P., Chaussain, J., & Job, J. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-6-1152 · Cited by 94
Growth hormone receptor antagonist improves insulin resistance in acromegaly
Rose, D. R., & Clemmons, D. R. (2002) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(02)00083-7 · Cited by 90
Bartke, A., Chandrashekar, V., Turyn, D., Steger, R. W., Debéljuk, L., Winters, T. A., Mattison, J. A., Danilovich, N., Croson, W., Wernsing, D. R., et al. (1999) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-121.x · Cited by 88
Self-citationGlucose and lipid homeostasis in the absence of human growth hormone
Merimee, T. J., Felig, P., Marliss, E. B., Fineberg, S. E., & Cahill, G. F. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106527 · Cited by 87
Dey, B. R., Furlanetto, R. W., & NISSLEY, P. S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3762 · Cited by 83
Peripheral Glucose Metabolism in Acromegaly
Foss, M. C., SAAD, M. J. A., Paccola, G. M. G. F., de Paula, F. J. A., Piccinato, C. E., & Moreira, A. C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-5-1048 · Cited by 80
Growth Hormone and Adipocyte Function in Obesity
Nam, S. Y., & Marcus, C. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053211 · Cited by 79
Effect of long-term rhGH administration in GH-deficient adults on fat cell epinephrine response
Beauville, M., Harant, I., Crampes, F., Rivière, D., Tauber, M., Tauber, J.-P., & Garrigues, M. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.263.3.e467 · Cited by 77
Ho, K. K. Y., Jenkins, A. B., Furler, S. M., Borkman, M., & Chisholm, D. J. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb01443.x · Cited by 72
Kilgour, E., Gout, I. T., & Anderson, N. G. (1996) · Biochemical Journal · doi:10.1042/bj3150517 · Cited by 71
Lippe, B. M., Kaplan, S. A., Golden, M. P., HENDRICKS, S. A., & Scott, M. L. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-3-507 · Cited by 70
Peraldi, P., Filloux, C., Emanuelli, B., Hilton, D., & Obberghen, E. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102209200 · Cited by 64
Thirone, A. C. P., Carvalho, C. R. D. O., & Saad, M. J. A. (1999) · Endocrinology · doi:10.1210/endo.140.1.6417 · Cited by 63
Brady, P. S., Marine, K. A., Brady, L. J., & Ramsay, R. R. (1989) · Biochemical Journal · doi:10.1042/bj2600093 · Cited by 59
Opposite Effects of Background Genotype on Muscle and Liver Insulin Sensitivity of Lipoatrophic Mice
Colombo, C., Haluzík, M., Cutson, J. J., Dietz, K. R., Marcus‐Samuels, B., Vinson, C., Gavrilova, O., & Reitman, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207665200 · Cited by 56
O’Connell, T., & Clemmons, D. R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020343 · Cited by 56
MacLeod, J. N., & Shapiro, B. (1988) · PubMed · Cited by 51
Effects of Growth Hormone Treatment in Obese Prepubertal Boys
Kamel, A. F., Norgren, S., Elimam, A., Danielsson, P., & Marcus, C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6492 · Cited by 48
Böni-Schnetzler, M., Hauri, C., & Zapf, J. (1999) · Diabetologia · doi:10.1007/s001250051134 · Cited by 45
Böni‐Schnetzler, M., Gosteli, M., Moritz, W., Froesch, E. R., & Zapf, J. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1169 · Cited by 41
Effect of low-dose human growth hormone on carbohydrate metabolism in children with hypopituitarism
Costin, G., Kogut, M. D., & Frasier, S. D. (1972) · The Journal of Pediatrics · doi:10.1016/s0022-3476(72)80133-1 · Cited by 39
Effects of fatty acids and growth hormone on liver fatty acid binding protein and PPARα in rat liver
Carlsson, L., Lindén, D., Jalouli, M., & Oscarsson, J. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.4.e772 · Cited by 38
Tanizawa, Y. (1997) · Endocrinology · doi:10.1210/en.138.10.4513 · Cited by 38
Effects of growth hormone on adipose tissue.
Carrel, A. L., & Allen, D. B. (2000) · PubMed · Cited by 34
Modulation of insulin secretion by leptin
Ceddia, R. B., William, W. N., Carpinelli, Â. R., & Curi, R. (1999) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(98)00185-2 · Cited by 29
Plasma Glucagon and Insulin Concentrations in Acromegaly
Trimble, E. R., Atkinson, A. B., Buchanan, K. D., & Hadden, D. R. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-3-626 · Cited by 28
Elkeles, R. S., Lowy, C., Wright, A. D., & Fraser, T. R. (1969) · The Lancet · doi:10.1016/s0140-6736(69)90327-4 · Cited by 27
Daugaard, Laustsen, J., Hansen, B., & Richter, E. A. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600127 · Cited by 18
Grunt, J., Crigler, J. F., Slone, D., & Soeldner, J. S. (1967) · PubMed Central · Cited by 14
Liebermeister, H., Solbach, H. G., Schilling, W., R�enauver, R., Meissner, H., Gr�neklee, D., Herberg, L., & Daweke, H. (1968) · Diabetologia · doi:10.1007/bf00430095 · Cited by 10
Nomura, S., Iishii, K., Inami, N., Kimura, E., & Urase, F. (2007) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000112637 · Cited by 2
Research works printed but not linked: 15
- Houssay, 1936, N. Engl. J. Med., 214, 961, 10.1056/NEJM193605142142001 · doi:10.1056/nejm193605142142001
- Beauville, 1992, Am. J. Physiol., 263, E467
- 10.1210/jc.85.4.1412 · doi:10.1210/jc.85.4.1412
- 10.1210/en.140.1.55 · doi:10.1210/en.140.1.55
- 10.1210/en.138.10.4301 · doi:10.1210/en.138.10.4301
- MacLeod, 1988, Lab. Anim. Sci., 38, 603
- Grunt, 1967, Yale J. Biol. Med., 40, 68
- 10.1016/S0022-3476(72)80134-3 · doi:10.1016/s0022-3476(72)80134-3
- 10.1007/BF01213677 · doi:10.1007/bf01213677
- 10.1507/endocrj.42.739 · doi:10.1507/endocrj.42.739
- Hansen, 1986, Am. J. Physiol., 250, E269
- Carrel, 2000, J. Pediatr. Endocrinol. Metab., 13(Suppl 2), 1003
- Richelsen, 1994, Am. J. Physiol., 266, E211
- 10.1210/jc.83.2.382 · DOI · Paper page
- 10.1016/0041-008X(85)90240-6 · doi:10.1016/0041-008x(85)90240-6
Cited by
Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009
Wilson, C. G., Tran, J. L., Erion, D. M., Vera, N. B., Febbraio, M., & Weiss, E. J. (2016) · Endocrinology · doi:10.1210/en.2015-1866 · Cited by 463
The Role of Liver-Derived Insulin-Like Growth Factor-I
Ohlsson, C., Mohan, S., Sjögren, K., Tivesten, A., Isgaard, J., Isaksson, O., Jansson, J.-O., & Svensson, J. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0010 · Cited by 453
Considerations in the Design of Hyperinsulinemic-Euglycemic Clamps in the Conscious Mouse
Ayala, J. E., Bracy, D. P., McGuinness, O. P., & Wasserman, D. H. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0686 · Cited by 403
Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1
LeRoith, D., & Yakar, S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0427 · Cited by 344
Self-citation
Metadata
- Authors
- Yakar, S., Setser, J., Zhao, H., Stannard, B., Haluzik, M., Glatt, V., Bouxsein, M. L., Kopchick, J. J., & LeRoith, D.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-01-01
- Volume
- 113
- Issue
- 1
- Pages
- 96-105
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1977873280
- Cited by
- 252
- References
- 66
- FWCI
- 10.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.